TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Sana Pharma Sverige AB
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
6,396
|
6,931
|
2,892 |
Financial expenses |
10
|
1
|
0 |
Earnings before taxes |
147
|
-3
|
140 |
EBITDA |
179
|
25
|
161 |
Total assets |
9,985
|
3,550
|
963 |
Current assets |
9,972
|
3,516
|
933 |
Current liabilities |
9,586
|
3,299
|
709 |
Equity capital |
399
|
251
|
254 |
- share capital |
50
![]() |
50
![]() |
50 |
Employees (average) |
4
![]() |
4
|
3 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
4.0%
|
7.1%
|
26.4% |
Turnover per employee |
1,599
|
1,733
|
964 |
Profit as a percentage of turnover |
2.3%
|
0.0%
|
4.8% |
Return on assets (ROA) |
1.6%
|
-0.1%
|
14.5% |
Current ratio |
104.0%
|
106.6%
|
131.6% |
Return on equity (ROE) |
36.8%
|
-1.2%
|
55.1% |
Change turnover |
-535
|
4,039
|
607 |
Change turnover % |
-8%
|
140%
|
27% |
Chg. No. of employees |
0
|
1
![]() |
1 |
Chg. No. of employees % |
0%
|
33%
|
50% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.